Peresolimab, a humanized IgG1 monoclonal antibody treatment for rheumatoid arthritis, shows promising results in phase 2a trial
Patient input in a digital health application enhances the patient-reported outcomes in rheumatoid arthritis
ASCORE study reports improved abatacept retention and clinical response rates in patients who received early subcutaneous abatacept
Study reports comparable treatment effects of biosimilars and reference biologics in rheumatoid arthritis
